Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested in receiving it.

HIV prevention is entering a new phase with the rise of innovative medications like the twice-yearly injectable lenacapavir.

For too long, conversations around HIV prevention have been wrapped in shame, confusion, or silence. But that’s starting to change, thanks to platforms like Mistr. As a queer-owned service built with ...

A new study shows low rates of pre-exposure prophylaxis (PrEP) prescribing to sexual and gender minority individuals living ...

Gandhi cited a recent study from the CDC showing that more than 2.2 million individuals in the US need PrEP, but only 336K ...

Many at-risk Americans either do not know about PrEP or don't have access. Here's why raising awareness is key to ending the ...

Declining investment in global health surveillance, research, and scientific innovation are happening as the need for vigilance has never been greater, writes Robert C. Gallo.

Three decades after Rae Lewis-Thornton became the face of HIV, the virus is still a major threat to Black women. She and experts explore why.

Chicago, Cook County and Illinois are on the cusp of ending the HIV epidemic in our city, county and state. But that progress ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...